Literature DB >> 16848690

Targeting invading macrophage-derived PGE2, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain.

Weiya Ma1, Rémi Quirion.   

Abstract

Immune and inflammatory responses occurring in an injured nerve have been generally believed to contribute to the generation and maintenance of neuropathic pain. In this review, the authors demonstrate the upregulation of COX-2/prostaglandin E2, IL-6 and calcitonin gene-related peptide in invading macrophages and discuss possible mechanisms involved in their upregulation and how they contribute to the maintenance of neuropathic pain. By acting on nociceptors in dorsal root ganglion and local inflammatory cells via autocrine or paracrine pathways, these inflammatory mediators facilitate spontaneous ectopic activity and sustain nociceptive responses, an important mechanism underlying both ongoing and evoked neuropathic pain state. Targeting these mediators in injured nerve may provide novel therapeutic avenues to more successfully treat nerve injury-associated neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16848690     DOI: 10.1517/14728222.10.4.533

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  10 in total

Review 1.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

Review 2.  Inflammation at the intersection of behavior and somatic symptoms.

Authors:  Michael R Irwin
Journal:  Psychiatr Clin North Am       Date:  2011-09

3.  Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat.

Authors:  Jelena M Janjic; Kiran Vasudeva; Muzamil Saleem; Andrea Stevens; Lu Liu; Sravan Patel; John A Pollock
Journal:  J Neuroimmunol       Date:  2018-02-25       Impact factor: 3.478

4.  Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy.

Authors:  Mitra Tavakoli; Omar Asghar; Uazman Alam; Ioannis N Petropoulos; Hassan Fadavi; Rayaz A Malik
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

5.  Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine.

Authors:  Mihály Balogh; Jelena M Janjic; Andrew J Shepherd
Journal:  Antioxid Redox Signal       Date:  2022-01       Impact factor: 8.401

6.  Differential regulation of immune responses and macrophage/neuron interactions in the dorsal root ganglion in young and adult rats following nerve injury.

Authors:  David Vega-Avelaira; Sandrine M Géranton; Maria Fitzgerald
Journal:  Mol Pain       Date:  2009-12-10       Impact factor: 3.395

Review 7.  Cytokine and chemokine regulation of sensory neuron function.

Authors:  Richard J Miller; Hosung Jung; Sonia K Bhangoo; Fletcher A White
Journal:  Handb Exp Pharmacol       Date:  2009

8.  Dynamic response to peripheral nerve injury detected by in situ hybridization of IL-6 and its receptor mRNAs in the dorsal root ganglia is not strictly correlated with signs of neuropathic pain.

Authors:  Václav Brázda; Ilona Klusáková; Ivana Hradilová Svíženská; Petr Dubový
Journal:  Mol Pain       Date:  2013-08-16       Impact factor: 3.395

9.  Phosphorylation at Ser 727 Increases STAT3 Interaction with PKCε Regulating Neuron-Glia Crosstalk via IL-6-Mediated Hyperalgesia In Vivo and In Vitro.

Authors:  Xiongjuan Li; Biqiang Zhou; Han Yang; Xinping Yang; Zhao Zhao; Zhenglong Pan; Xinran Liao; Wenling Jian; Yuqiang Liu; Han Lu; Qingsheng Xue; Yan Luo; Buwei Yu; Huansen Huang; Daqing Ma; Zhiheng Liu
Journal:  Mediators Inflamm       Date:  2022-01-28       Impact factor: 4.711

Review 10.  Mediators of Neuropathic Pain; Focus on Spinal Microglia, CSF-1, BDNF, CCL21, TNF-α, Wnt Ligands, and Interleukin 1β.

Authors:  Paul A Boakye; Shao-Jun Tang; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.